Evidence map›Paper›PMID 33217309›Full record

ArticleAmerican journal of human genetics2020

A Recurrent Gain-of-Function Mutation in CLCN6, Encoding the ClC-6 Cl

Maya M Polovitskaya, Carlo Barbini, Diego Martinelli, Frederike L Harms, F Sessions Cole, Paolo Calligari, Gianfranco Bocchinfuso, Lorenzo Stella, Andrea Ciolfi, Marcello Niceta and 10 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Ion transport as a determinant of membrane fusion and fission.Nature structural & molecular biology · 2026
    Review
  2. Article
  3. Article
  4. The function of chloride channels in digestive system disease (Review).International journal of molecular medicine · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Distinct ClC-6 and ClC-7 ClThe Journal of physiology · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Maya M PolovitskayaLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany; Max-Delbrück-Centrum für Molekulare Medizin (MDC), 13125 Berlin, Germany.
Carlo BarbiniLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany; Max-Delbrück-Centrum für Molekulare Medizin (MDC), 13125 Berlin, Germany.
Diego MartinelliGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Frederike L HarmsInstitute for Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
F Sessions ColeDivision of Newborn Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, and St. Louis Children's Hospital, St. Louis, MO 63110, USA.
Paolo CalligariDepartment of Chemical Science and Technologies, University "Tor Vergata," 00133 Rome, Italy.
Gianfranco BocchinfusoDepartment of Chemical Science and Technologies, University "Tor Vergata," 00133 Rome, Italy.
Lorenzo StellaDepartment of Chemical Science and Technologies, University "Tor Vergata," 00133 Rome, Italy.
Andrea CiolfiGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Marcello NicetaGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Teresa RizzaGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Marwan ShinawiDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, and St. Louis Children's Hospital, St. Louis, MO 63110, USA.
Kathleen SiscoDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, and St. Louis Children's Hospital, St. Louis, MO 63110, USA.
Jessika JohannsenChildren's Hospital, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Jonas DeneckeChildren's Hospital, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Rosalba CarrozzoGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Daniel J WegnerDivision of Newborn Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, and St. Louis Children's Hospital, St. Louis, MO 63110, USA.
Kerstin KutscheInstitute for Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Marco TartagliaGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy. Electronic address: marco.tartaglia@opbg.net.
Thomas J JentschLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany; Max-Delbrück-Centrum für Molekulare Medizin (MDC), 13125 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany. Electronic address: jentsch@fmp-berlin.de.
Bambino Gesù Children's Hospital · ITSt. Louis Children's Hospital · USUniversität Hamburg · DEMax Delbrück Center · DEUniversity of Rome Tor Vergata · IT

Funding

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE UNDIAGNOSED DISEASES NETWORK CLINICAL SITEU01HG010215 · NHGRI · WASHINGTON UNIVERSITY · PI DICKSON, PATRICIA I · 2018 to 2022
$3.4M
NHGRI NIH HHS U01 HG010215
6 · The paper itself

Abstract

Dysfunction of the endolysosomal system is often associated with neurodegenerative disease because postmitotic neurons are particularly reliant on the elimination of intracellular aggregates. Adequate function of endosomes and lysosomes requires finely tuned luminal ion homeostasis and transmembrane ion fluxes. Endolysosomal CLC Cl

Indexed as

Gain of Function MutationAllelesAnimalsChildChloride ChannelsCHO CellsCricetulusElectrophysiologyEndosomesFemaleHeLa CellsHeterozygoteHomeostasisHumansHydrogen-Ion ConcentrationInfantbafilomycin AChloride ChannelsCLCN6 protein, humanClcn6 protein, mouseIonsLamp1 protein, mouseLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsMacrolidesanion/proton antiportchannelopathychloride channelchloride/proton exchangecopper metabolismgain of functiongating glutamateluminal pHneurogenic bladdervacuole fusion

Identifiers

PMID33217309
PMCPMC7820737
OpenAlexW3105447669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.